TPIV100
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TPIV100, covering 2023-12-18 to 2023-12-18. Get the full timeline:
Most recent: Clinical Trial Update: TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery [Phase 2]